Artificial Intelligence and Machine Learning-Based Approaches for Neurodegenerative Diseases Diagnosis
Keywords:
Neurodegenerative diseases, Machine learning, Diagnosis, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis (ALS)Abstract
This review paper delves into the transformative impact of machine learning on the diagnosis of neurodegenerative diseases, such as Alzheimer's, Parkinson's, and ALS. The importance of high-quality medical data, diverse data sources, and specific machine learning algorithms, including Support Vector Machines, Convolutional Neural Networks, and Long Short-Term Memory networks, is emphasized. Case studies showcase the practical applications of machine learning, highlighting the methodologies, findings, and limitations of various projects. Machine learning's significance in advancing neurodegenerative disease diagnosis lies in its ability to enable early detection, enhance diagnostic accuracy, and facilitate personalized treatment strategies. The future of machine learning in this field is marked by the integration of diverse data modalities, interpretable models, ethical considerations, the recognition of disease heterogeneity, and the pursuit of early detection and intervention. Collaboration among researchers, clinicians, and technologists is pivotal for realizing the potential of machine learning in improving patient care and quality of life for individuals affected by these challenging diseases. As we venture into the future, machine learning promises to continue pushing the boundaries of what is achievable in neurodegenerative disease diagnosis.
References
[1]. Alzheimer's Association. (2020). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 16(3), 391-460. https://doi.org/10.1002/alz.12068
[2]. Brown, R. H., & Al-Chalabi, A. (2017). Amyotrophic lateral sclerosis. New England Journal of Medicine, 377(2), 162-172. https://doi.org/10.1056/NEJMra1603471
[3]. Prince, M., Wimo, A., Guerchet, M., Ali, G. C., Wu, Y. T., & Prina, M. (2015). World Alzheimer Report 2015: The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer's Disease International.
[4]. Shailaja, K., Banoth Seetharamulu, and M. A. Jabbar. "Machine learning in healthcare: A review." 2018 Second international conference on electronics, communication and aerospace technology (ICECA). IEEE, 2018. https://doi.org/10.1109/ICECA.2018.8474918
[5]. Kalia, Lorraine V., and Anthony E. Lang. "Parkinson's disease." The Lancet 386.9996 (2015): 896-912. https://doi.org/10.1016/S0140-6736(14)61393-3
[6]. Obermeyer, Z., & Emanuel, E. J. (2016). Predicting the future - big data, machine learning, and clinical medicine. New England Journal of Medicine, 375(13), 1216-1219. https://doi.org/10.1056/NEJMp1606181
[7]. Esteva, Andre, et al. "Dermatologist-level classification of skin cancer with deep neural networks." nature 542.7639 (2017): 115-118. https://doi.org/10.1038/nature21056
[8]. De Bruijne, Marleen. "Machine learning approaches in medical image analysis: From detection to diagnosis." Medical image analysis 33 (2016): 94-97. https://doi.org/10.1016/j.media.2016.06.032
[9]. Litjens, Geert, et al. "A survey on deep learning in medical image analysis." Medical image analysis 42 (2017): 60-88. https://doi.org/10.1016/j.media.2017.07.005
[10]. Jack, Clifford R., et al. "The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods." Journal of magnetic resonance imaging 27.4 (2008): 685-691.
[11]. Marek, Krzysztof, et al. "The Parkinson's Progression Markers Initiative (PPMI)." Progress in neurobiology 95.4 (2011): 429-435.
[12]. Marcus, David S., et al. "Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults." Journal of cognitive neuroscience 19.9 (2007): 1498-1507. https://doi.org/10.1162/jocn.2007.19.9.1498
[13]. Di Martino, Adriana, et al. "The Autism Brain Imaging Data Exchange (ABIDE) collaborative data set." NeuroImage: Clinical 6 (2014): 986-1002.
[14. Shafto, Michael, et al. "The Cambridge Centre for Ageing and Neuroscience (CAM-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of cognitive ageing." Neuroscience & Biobehavioral Reviews 34.12 (2010): 1487-1512.
[15]. Klöppel, Stefan, et al. "Automatic classification of MR scans in Alzheimer's disease." Brain 131.3 (2008): 681-689. https://doi.org/10.1093/brain/awm319
[16]. Sarraf, Saman, et al. "DeepAD: Alzheimer's disease classification via deep convolutional neural networks using MRI and fMRI." BioRxiv (2016): 070441. https://doi.org/10.1101/070441
[17]. Ravì, Daniele, et al. "Deep learning for health informatics." IEEE journal of biomedical and health informatics 21.1 (2016): 4-21. https://doi.org/10.1109/JBHI.2016.2636665
[18]. Khajeh, M. G., & Heidari, M. (2016). A random forest classifier for the prediction of pre-Alzheimer and Alzheimer's disease. Current Alzheimer Research, 13(5), 527-534.
[19]. Eskildsen, Simon F., et al. "BEaST: brain extraction based on nonlocal segmentation technique." NeuroImage 59.3 (2012): 2362-2373. https://doi.org/10.1016/j.neuroimage.2011.09.012
[20]. Marek, Kenneth, et al. "The Parkinson progression marker initiative (PPMI)." Progress in neurobiology 95.4 (2011): 629-635.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Surya Pratap Singh, Sushil Kumar Shukla , Ramakant Yadav
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Re-users must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. This license allows for redistribution, commercial and non-commercial, as long as the original work is properly credited.
7
